Has Ara Klijian, MD received payments from drug or device companies?

Yes. Drug and device makers reported $916,073 in general payments to Ara Klijian, MD across 901 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ara Klijian, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ara Klijian, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ara Klijian, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Murrieta, CANPI 1831134162

Payments from drug & device makers

$916,073in general payments, 2019–2025

Across 901 payments — averaging $1016.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Davol Inc.$408K
La Jolla Pharmaceutical Company$399K
Mallinckrodt Enterprises LLC$45K
Acacia Pharma Inc$17K
Eagle Pharmaceuticals, Inc.$16K
BTG International Inc.$12K
plus $19K from 38 others

What the payments were for

Consulting fees$65,4077%
Speaking & faculty fees$696,28676%
Travel & lodging$100,37711%
Food & beverage$29,0213%
Education$24,9823%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Davol Inc.	376	$408,296
La Jolla Pharmaceutical Company	324	$399,447
Mallinckrodt Enterprises LLC	46	$44,803
Acacia Pharma Inc	23	$16,561
Eagle Pharmaceuticals, Inc.	13	$15,814
BTG International Inc.	6	$12,362
Mallinckrodt Hospital Products Inc.	7	$8,463
AstraZeneca	11	$1,286
BD	9	$1,046
Johnson & Johnson(3 entities)	13	$837
On Target Laboratories, Inc	16	$657
Medtronic(2 entities)	5	$651
Pulmonx Corporation	5	$636
AOP Health US, LLC	2	$511
Cvrx, Inc.	5	$458
Lemaitre Vascular, Inc.	4	$370
Heron Therapeutics, Inc.	2	$313
Insmed, Inc.	2	$250
AbbVie	2	$250
Actelion Pharmaceuticals US, Inc.	2	$249
Bayer	2	$248
Inari Medical, Inc.	1	$219
Elevate Surgical Co	2	$215
Acelrx Pharmaceuticals, Inc.	2	$160
Merck	2	$155
Abbott	1	$147
Auris Health, Inc.	1	$141
Sanofi-aventis U.S. LLC	1	$138
Bard Access Systems, Inc.	1	$126
Chiesi USA, Inc.	1	$125
Otsuka America Pharmaceutical, Inc.	1	$122
Portola Pharmaceuticals, LLC	1	$118
Boehringer Ingelheim	1	$118
Regeneron Healthcare Solutions, Inc.	1	$117
Boston Scientific	1	$112
TELA Bio, Inc.	1	$111
United Therapeutics Corporation	1	$100
Argentum Medical	1	$89
Vero Biotech Inc.	1	$75
Intuitive Surgical	1	$59
Baxter Healthcare	1	$47
Atricure, Inc.	1	$31
Sanofi	1	$24
GSK	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$916,073 in reported general payments places this provider in the 95th percentile of 546 thoracic surgery (cardiothoracic vascular surgery) providers in California.

See all thoracic surgery (cardiothoracic vascular surgery) providers in California →

Medicare billing

Part B allowed, 2024

$182,725

Medicare patients

Services billed

346

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Acetaminophen-CodeineAcetaminophen With Codeine	12	$128

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Murrieta

Thomas FogartyPortola Valley$3.7M
Steven GundryPalm Springs$1.6M
Gregory FontanaThousand Oaks$1.4M
Gansevoort DunningtonSaint Helena$963K
Armin KiankhooySaint Helena$941K
Fernando FleischmanLos Angeles$901K
Michael FischbeinPalo Alto$899K
Jay LeeLos Angeles$856K
William HiesingerPalo Alto$815K
Vaughn StarnesLos Angeles$771K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →